Saltar al contenido principal
Elsevier

Advances in Immunology

  • 1 Edición, Volumen 139 - 21 de septiembre de 2018
  • Última edición
  • Editor: Frederick Alt
  • Idioma: Inglés

Advances in Immunology, Volume 139, the latest issue of a long-established and highly respected publication, presents current developments and comprehensive reviews in immunolog… Leer más

Descripción

Advances in Immunology, Volume 139, the latest issue of a long-established and highly respected publication, presents current developments and comprehensive reviews in immunology. Articles address the wide range of topics that comprise immunology, with this release including chapters on Alzheimer's and its innate receptors, the field of immune orchestration by small molecules, like chemokines and lipids, the role of AID in the first checkpoint, and the design of vaccine strategies to elicit HIV-1 broadly neutralizing antibodies.

Puntos claves

  • Contains contributions from leading authorities in immunology
  • Informs and updates on the latest developments in the field of immunology

De interès para

Immunologists and infectious disease specialists, cell biologists and hematologists

Índice

1. The Microglial Response to Neurodegenerative Disease
Wilbur M. Song and Marco Colonna

2. The First Tolerance Checkpoint in Mice and Humans: Control by AID
Masayuki Kuraoka, Eric Meffre and Garnett Kelsoe

3. RAG Chromatin Scanning During V(D)J Recombination and Chromatin Loop Extrusion are Related Processes
Sherry Lin, Zhaoqing Ba, Frederick W. Alt and Yu Zhang

Detalles del producto

  • Edición: 1
  • Última edición
  • Volumen: 139
  • Publicado: 21 de septiembre de 2018
  • Idioma: Inglés

Sobre el editor

FA

Frederick Alt

Frederick W. Alt is a Howard Hughes Medical Institute (HHMI) Investigator and Director of the Program in Cellular and Molecular Medicine (PCMM) at Boston Children's Hospital (BCH). He is the Charles A. Janeway Professor of Pediatrics and Professor of Genetics at Harvard Medical School. He works on elucidating mechanisms that generate antigen receptor diversity and, more generally, on mechanisms that generate and suppress genomic instability in mammalian cells, with a focus on the immune and nervous systems. Recently, his group has developed senstive genome-wide approaches to identify mechanisms of DNA breaks and rearrangements in normal and cancer cells. He has been elected to the U.S. National Academy of Sciences, the U.S. National Academy of Medicine, and the European Molecular Biology Organization. His awards include the Albert Szent-Gyorgyi Prize for Progress in Cancer Research, the Novartis Prize for Basic Immunology, the Lewis S. Rosensteil Prize for Distinugished work in Biomedical Sciences, the Paul Berg and Arthur Kornberg Lifetime Achievement Award in Biomedical Sciences, and the William Silan Lifetime Achievement Award in Mentoring from Harvard Medical School.
Afiliaciones y experiencia
Professor of Pediatrics and Professor of Genetics, Harvard Medical School, Boston, MA, USA

Ver libro en ScienceDirect

Lee Advances in Immunology en ScienceDirect